Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 128
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
J Obstet Gynaecol Res ; 45(5): 1079-1083, 2019 May.
Artículo en Inglés | MEDLINE | ID: mdl-30701637

RESUMEN

Nephroblastoma (also known as Wilms' tumor) mainly occurs in the kidneys of children. Nephroblastoma outside the kidneys may be observed in three situations: primary disease, metastatic disease and nephroblastoma arising in teratoma. Teratoma with nephroblastoma (TWN) of the adult ovary is a rare tumor and only one case has been reported. We report an unusual adult case of ovarian TWN presented to us with acute abdomen due to the spontaneous rupture of the ovary. The rupture occurred at the site of TWN, while contralateral ovary with only mature cystic teratoma component had no rupture. After one and a half months of the ovary sparing surgery, the tumor disseminated to the splenic hilum and the omentum. A complete staging with maximum cytoreduction followed by adjuvant chemotherapy were performed. She remains disease free until present.


Asunto(s)
Neoplasias Ováricas/diagnóstico , Rotura Espontánea/diagnóstico , Teratoma/diagnóstico , Tumor de Wilms/diagnóstico , Adulto , Femenino , Humanos , Neoplasias Ováricas/terapia , Rotura Espontánea/terapia , Teratoma/terapia , Tumor de Wilms/terapia
2.
Int J Gynecol Cancer ; 28(9): 1772-1780, 2018 11.
Artículo en Inglés | MEDLINE | ID: mdl-30358702

RESUMEN

OBJECTIVE: The aim of this study was to evaluate the incidence and risk factors of gestational trophoblastic neoplasia (GTN) from hydatidiform moles (HMs) cytogenetically diagnosed in a prospective cohort setting. METHODS: The prospective observational cohort study included cases of cytogenetically defined molar pregnancies, which were diagnosed by a multiplex short tandem repeat polymorphism analysis. Cases were classified as androgenetic complete HMs (CHMs), diandric monogynic triploid partial HMs (PHMs), or biparental abortion. Gestational trophoblastic neoplasia was diagnosed according to the International Federation of Gynecology and Obstetrics 2000 criteria. Incidences for each category, that is, CHM, PHMs, and biparental abortion, were calculated. Clinical variables (age, partner age, gravidity, parity, height, weight, BMI, and gestational age) and laboratory data (serum human chorionic gonadotropin [hCG], white blood cell count, hemoglobin, and platelet count) were compared between spontaneous remission cases and GTN cases in androgenetic CHMs. RESULTS: Among 401 cases, 380 were classified as follows: 232 androgenetic CHMs, 60 diandric monogynic PHMs, and 88 biparental abortions. A total of 35 cases (15.1%) of CHMs, but only 1 case of PHM (1.7%) and no biparental abortions, exhibited progression to GTN. The hCG value before evacuation was significantly higher in GTN cases than in spontaneous remission cases (P = 0.001, Kruskal-Wallis test). Patient age was also significantly higher in GTN cases than in spontaneous remission cases (P = 0.002, Student t test). CONCLUSIONS: Under the cohort cytogenetic diagnosis setting, the traditional risk factors for GTN after molar pregnancy, hCG value before evacuation and age, were confirmed in androgenetic CHMs. The risk of GTN was lower for PHMs than for CHMs. However, 1 patient with cytogenetic PHMs developed into GTN.


Asunto(s)
Enfermedad Trofoblástica Gestacional/genética , Neoplasias Uterinas/genética , Adulto , Gonadotropina Coriónica/sangre , Estudios de Cohortes , Femenino , Enfermedad Trofoblástica Gestacional/sangre , Enfermedad Trofoblástica Gestacional/patología , Humanos , Repeticiones de Microsatélite , Polimorfismo Genético , Embarazo , Estudios Prospectivos , Neoplasias Uterinas/sangre , Neoplasias Uterinas/patología
3.
Am J Med Genet A ; 170A(4): 1029-34, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26782978

RESUMEN

We describe a Gorlin syndrome (GS) case with two different second hit mutations of PTCH1, one in a keratocystic odontogenic tumor (KCOT) and the other in an ovarian leiomyoma. GS is a rare genetic condition manifesting as multiple basal cell nevi associated with other features such as medulloblastomas, skeletal abnormalities, and ovarian fibromas. A 21-year-old Japanese woman with a history of two KCOTs was diagnosed with GS according to clinical criteria. A PTCH1 mutation, c.1427del T, was detected in peripheral blood. A novel PTCH1 mutation, c.264_265insAATA, had been found in the maxillary KCOT as a second hit mutation. More recently, the ovarian tumor was detected during a gynecological examination. Laparoscopic adnexectomy was performed, and the pathological diagnosis of the ovarian tumor was leiomyoma. Interestingly, another novel mutation, loss of heterozygosity spanning from 9q22.32 to 9q31.2, including PTCH1 and 89 other genes, was detected in this ovarian tumor, providing evidence of a second hit mutation. This is the first report describing a GS-associated ovarian tumor carrying a second hit in the PTCH1 region. We anticipate that accumulation of more cases will clarify the importance of second hit mutations in ovarian tumor formation in GS.


Asunto(s)
Síndrome del Nevo Basocelular/complicaciones , Síndrome del Nevo Basocelular/genética , Leiomioma/complicaciones , Leiomioma/genética , Neoplasias Ováricas/complicaciones , Neoplasias Ováricas/genética , Receptor Patched-1/genética , Síndrome del Nevo Basocelular/diagnóstico , Cromosomas Humanos Par 9 , Hibridación Genómica Comparativa , Análisis Mutacional de ADN , Femenino , Humanos , Inmunohistoquímica , Leiomioma/diagnóstico , Leiomioma/cirugía , Imagen por Resonancia Magnética , Mutación , Neoplasias Ováricas/diagnóstico , Neoplasias Ováricas/cirugía , Adulto Joven
4.
Hum Reprod ; 30(2): 406-16, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25475585

RESUMEN

STUDY QUESTION: Can regenerative-medicine techniques using oral mucosal epithelial cell sheets (OMECS) provide a new treatment method for intrauterine adhesions (IUA) which cause female infertility? SUMMARY ANSWER: Transplantation of OMECS was confirmed to be effective in preventing IUA after endometrial damage in rats. WHAT IS KNOWN ALREADY: Uterine disorders such as IUA, commonly known as Asherman's syndrome, are one factor that can result in infertility. Clinical therapy for this kind of disease is targeted at the prevention of re-adhesion by surgical synechiotomy, administration of hormones after the operation, and the use of intrauterine devices. Recently, a new approach called 'cell-sheet engineering', which harvests confluent culture cells as a contiguous cell sheet having intact cell-cell junctions and an extracellular matrix, without having to use enzymatic treatment, has been developed for tissue regeneration. STUDY DESIGN, SIZE, DURATION: OMECS were prepared from rat oral mucosal tissues. An IUA model was made in rat uteri, and OMECS were transplanted into the model. Uteri transplanted with OMECS were compared with the non-transplanted control uteri by histological analysis at 1, 2 and 8 days after surgery (n = 3). PARTICIPANTS/MATERIALS, SETTING, METHODS: Oral mucosal tissues were resected from neonatal rats, and oral mucosal epithelial cells were collected with enzymatic treatment. An isolated cell suspension was seeded on a temperature-responsive cell culture-insert and incubated. After being detached from the insert, a cell sheet was transplanted onto the endometrium defect. At 1, 2 and 8 days after surgery, uteri were resected and examined. MAIN RESULTS AND THE ROLE OF CHANCE: Histological examination of the non-treated specimens at 1, 2 and 8 days after surgery did not show any uterine cavities typically caused by IUA. In contrast, the histology of uteri transplanted with OMECS immediately after endometrial damage showed the presence of uterine cavities, and furthermore, stratified squamous epithelial cells on the luminal surface (n = 3). LIMITATIONS, REASONS FOR CAUTION: The results of this study are difficult to apply directly to humans, because the structure and function of rat uteri are different from those of human. WIDER IMPLICATIONS OF THE FINDINGS: Transplantation of OMECS offers a reliable method not only to protect the woman's fertility from intrauterine re-adhesion after synechiotomy for IUA or uterine lumen adhesion but also to prevent adhesion after any intrauterine surgery in clinical cases.


Asunto(s)
Modelos Animales de Enfermedad , Ginatresia/terapia , Mucosa Bucal/citología , Regeneración , Adherencias Tisulares/terapia , Ingeniería de Tejidos , Útero/fisiología , Animales , Animales Recién Nacidos , Biomarcadores/metabolismo , Células Cultivadas , Cruzamientos Genéticos , Femenino , Proteínas Fluorescentes Verdes/genética , Proteínas Fluorescentes Verdes/metabolismo , Ginatresia/cirugía , Inmunohistoquímica , Mucosa Bucal/inmunología , Mucosa Bucal/metabolismo , Infiltración Neutrófila , Ratas Endogámicas F344 , Ratas Desnudas , Ratas Transgénicas , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Adherencias Tisulares/cirugía , Útero/citología , Útero/inmunología , Útero/metabolismo
5.
Gynecol Oncol ; 139(3): 429-32, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26456138

RESUMEN

OBJECTIVE: To determine the primary remission rates and predictors of drug resistance in patients with post-molar low-risk gestational trophoblastic neoplasia (GTN) who were treated with a 5-day intramuscular methotrexate (5-day IM MTX) or a 5-day drip infusion etoposide (5-day DIV ETP) regimen. METHODS: Between 1980 and 2014, 166 consecutive patients with low-risk post-molar GTN were initially treated with a 5-day IM MTX or a 5-day DIV ETP regimen. The primary remission rates, changes in chemotherapy due to drug resistance or toxicity, and relapse rates were compared. Furthermore, we analyzed the factors that influenced the development of resistance to MTX. RESULTS: Primary remission rates were significantly higher among the ETP-treated patients than among the MTX-treated patients. Among the 42 patients who required a change in chemotherapy, 23 patients (22.6%) and 4 patients (6.3%) were diagnosed as being resistant to MTX and EPT, respectively. Maternal age and the presence of metastasis did not significantly influence the development of MTX resistance, although higher FIGO scores and pre-treatment human chorionic gonadotropin (hCG) levels of >5×10(4)mIU/mL were significantly more common among patients who developed MTX resistance. Moreover, a <30% decrease in hCG after the first cycles of MTX chemotherapy was significantly associated with the development of MTX resistance. CONCLUSIONS: All patients with low-risk GTN eventually achieved complete remission, although several patients developed drug resistance to the first-line chemotherapy. A <30% decrease in hCG during the first chemotherapy cycle may be an early indicator of drug resistance after commencing a 5-day MTX regimen.


Asunto(s)
Antimetabolitos Antineoplásicos/administración & dosificación , Antineoplásicos Fitogénicos/administración & dosificación , Resistencia a Antineoplásicos , Etopósido/administración & dosificación , Mola Hidatiforme/tratamiento farmacológico , Metotrexato/administración & dosificación , Recurrencia Local de Neoplasia/tratamiento farmacológico , Neoplasias Uterinas/tratamiento farmacológico , Adulto , Antimetabolitos Antineoplásicos/efectos adversos , Antineoplásicos Fitogénicos/efectos adversos , Gonadotropina Coriónica/sangre , Esquema de Medicación , Sustitución de Medicamentos , Etopósido/efectos adversos , Femenino , Humanos , Mola Hidatiforme/sangre , Mola Hidatiforme/secundario , Metotrexato/efectos adversos , Embarazo , Estudios Retrospectivos , Resultado del Tratamiento , Neoplasias Uterinas/sangre , Neoplasias Uterinas/patología , Adulto Joven
6.
Int J Gynecol Cancer ; 25(5): 926-30, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24987912

RESUMEN

OBJECTIVES: This study aimed to identify the clinical and demographic characteristics and prognosis of patients with conditions diagnosed with postpartum choriocarcinoma based on the International Federation of Gynecology and Obstetrics 2000 prognosis scoring system or based on pathologically confirmed choriocarcinoma and to analyze the patients' clinical symptoms for early detection of this disease. METHODS/MATERIALS: Between January 1983 and August 2013, 24 consecutive women with postpartum choriocarcinoma were treated at 2 hospitals. Data on clinical and demographic characteristics, including initial presenting symptoms, type of antecedent pregnancy, fetal complications, and prognosis of these patients, were analyzed. According to the time interval between the previous delivery and the onset of disease, patients were divided into 2 groups: the short and long interval groups. RESULTS: The most common symptom among the 24 patients with postpartum choriocarcinoma was irregular vaginal bleeding (14/24); in some cases, bleeding was caused by metastatic foci (7/24). Massive genital bleeding causing emergency hysterectomy and several obstetric complications, such as unknown severe fetal anemia and fetal growth retardation, was only observed in the short interval group. The overall primary remission rate was 91.7%. CONCLUSIONS: The most common symptom of patients with postpartum choriocarcinoma in the short and long interval groups was genital bleeding, and the overall prognosis may be improved by introduction of an appropriate chemotherapy regimen. Careful pathological examination of the placenta is needed in cases of fetomaternal hemorrhage, unknown fetal anemia, and abnormal obstetric events, including premature delivery, still birth, and infantile growth retardation, for the early detection of intraplacental choriocarcinoma.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Coriocarcinoma/diagnóstico , Coriocarcinoma/terapia , Periodo Posparto , Neoplasias Uterinas/diagnóstico , Neoplasias Uterinas/terapia , Adulto , Terapia Combinada , Femenino , Estudios de Seguimiento , Humanos , Histerectomía , Persona de Mediana Edad , Estadificación de Neoplasias , Embarazo , Pronóstico , Estudios Retrospectivos
7.
Biochem Biophys Res Commun ; 446(1): 335-40, 2014 Mar 28.
Artículo en Inglés | MEDLINE | ID: mdl-24602616

RESUMEN

Uterus is a female specific reproductive organ and plays critical roles in allowing embryo to grow. Therefore, the endometrial disorders lead to female infertility. Hence, the regeneration of endometrium allowing fertilized ovum to implant might be valuable in the field of fertility treatment. Recently, cell sheet engineering using a temperature-responsive culture dish has advanced in regenerative medicine. With this technology, endometrial cells were harvested as a contiguous cell sheet by reducing temperature. Firstly, mouse endometrial cell sheets were re-cultured for 3 days to evaluate the function. Histological analyses revealed that endometrial epithelial cell-specific cytokeratin 18 and female-specific hormone receptors, estrogen receptor ß and progesterone receptor, were expressed. Furthermore, endometrial epithelial cells constructed epithelial layer at the apical side. Then, endometrial cell sheets from green-fluorescent-protein rat cells were transplanted onto the buttock muscle of nude rat for evaluating the function in vivo. Histological analyses showed that endometrial cell sheets reconstructed endometrium-like tissue, which was found to form uterus-specific endometrial glands having hormonal receptor to estrogen. In this study, endometrial cell sheets were speculated to contribute to the regeneration of functional endometrium as a new therapy.


Asunto(s)
Endometrio/citología , Endometrio/fisiología , Ingeniería de Tejidos/métodos , Animales , Animales Modificados Genéticamente , Endometrio/trasplante , Células Epiteliales/citología , Células Epiteliales/metabolismo , Receptor beta de Estrógeno/genética , Receptor beta de Estrógeno/metabolismo , Femenino , Proteínas Fluorescentes Verdes/genética , Proteínas Fluorescentes Verdes/metabolismo , Queratina-18/metabolismo , Ratones , Ratones Endogámicos C57BL , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Ratas Endogámicas F344 , Ratas Desnudas , Receptores de Progesterona/genética , Receptores de Progesterona/metabolismo , Regeneración/genética , Regeneración/fisiología
8.
BMC Pregnancy Childbirth ; 13: 156, 2013 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-23915223

RESUMEN

BACKGROUND: To determine the major predictive factors for fetal acidemia in placental abruption. METHODS: A retrospective review of pregnancies with placental abruption was performed using a logistic regression model. Fetal acidemia was defined as a pH of less than 7.0 in umbilical artery. The severe abruption score, which was derived from a linear discriminant function, was calculated to determine the probability of fetal acidemia. RESULTS: Fetal acidemia was seen in 43 survivors (43/222, 19%). A logistic regression model showed bradycardia (OR (odds ratio) 50.34, 95% CI 11.07-228.93), and late decelerations (OR 15.13, 3.05-74.97), but not abnormal ultrasonographic findings were to be associated with the occurrence of fetal acidemia. The severe abruption score was calculated for the occurrence of fetal acidemia, using 6 items including vaginal bleeding, gestational age, abdominal pain, abnormal ultrasonographic finding, late decelerations, and bradycardia. CONCLUSIONS: An abnormal FHR pattern, especially bradycardia is the most significant risk factor in placental abruption predicting fetal acidemia, regardless of the presence of abnormal ultrasonographic findings or gestational age.


Asunto(s)
Desprendimiento Prematuro de la Placenta/sangre , Ácidos/sangre , Sangre Fetal/química , Enfermedades Fetales/sangre , Dolor Abdominal/complicaciones , Desprendimiento Prematuro de la Placenta/diagnóstico por imagen , Desprendimiento Prematuro de la Placenta/cirugía , Área Bajo la Curva , Bradicardia/complicaciones , Cesárea , Femenino , Enfermedades Fetales/etiología , Edad Gestacional , Frecuencia Cardíaca Fetal , Humanos , Concentración de Iones de Hidrógeno , Modelos Logísticos , Masculino , Valor Predictivo de las Pruebas , Embarazo , Curva ROC , Estudios Retrospectivos , Factores de Riesgo , Índice de Severidad de la Enfermedad , Ultrasonografía , Arterias Umbilicales , Hemorragia Uterina/complicaciones
9.
J Obstet Gynaecol Res ; 39(2): 500-3, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22925573

RESUMEN

AIM: Measles during pregnancy has deleterious effects on both perinatal and maternal outcomes. In Japan, local epidemics of measles and cases of measles during pregnancy are still being reported; therefore, the seroprevalence of antibodies to measles is suspected to be still not sufficient. The aim of this study was to analyze the seroprevalence of antibodies to measles in Japanese pregnant women and estimate the percentage of these women who require vaccination or revaccination against measles. MATERIAL AND METHODS: We analyzed the seroprevalence of immunity to measles by the neutralization test in 10 349 pregnant women in the first trimester managed at the National Center for Child Health and Development between February 2004 and December 2010. The neutralization test titers were interpreted as follows: ≧1:8, seropositive; =4, low-positive; ≦4, seronegative. RESULTS: Of the total number of pregnant women tested, 7408 (71.6%) were seropositive, 1864 (18.0%) were low-positive, and 1079 (10.4%) were seronegative for measles antibodies, respectively. CONCLUSION: Our results revealed that 28% of our pregnant population was seronegative or low-positive for measles antibodies, and thought to require revaccination or vaccination. Screening for measles immunity might be advisable for women of childbearing age.


Asunto(s)
Anticuerpos Antivirales/análisis , Virus del Sarampión/inmunología , Virus del Sarampión/aislamiento & purificación , Sarampión/inmunología , Femenino , Humanos , Japón/epidemiología , Sarampión/epidemiología , Evaluación de Necesidades , Embarazo , Primer Trimestre del Embarazo , Estudios Seroepidemiológicos
10.
Pract Lab Med ; 37: e00343, 2023 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-38025990

RESUMEN

Objectives: Human chorionic gonadotropin (hCG) levels are essential for the management of trophoblastic diseases. This study aimed to compare the sensitivities and relationships of two hCG measurement methods (total hCG and the free ß-subunit of hCG) in managing gestational trophoblastic disease (GTD). Design and Methods: We analyzed data from patients treated for GTD at Chiba University Hospital between 2008 and 2019. We focused on cases where both total hCG (mIU/mL) and the free ß-subunit of hCG (ng/mL) were measured on the same day. Results: Out of 80 patients (mean age 38.9 ± 11.7 years) and 158 measurements, 26 had values below the sensitivity threshold for both tests. Fifty-nine measurements were positive for total hCG but below the sensitivity threshold for the free ß-subunit of hCG, whereas only two showed the opposite. Seventy-one measurements were positive for both total hCG and the free ß-subunit of hCG. There was a significant correlation between total hCG and the free ß-subunit of hCG with both positive values, (r = 0.94, p < 0.001; Spearman's correlation test). Of the 85 measurements with undetectable free ß-subunit levels, 26 also had undetectable total hCG levels. However, total hCG was detectable in 59 patients from these cases, with a median value (interquartile range) of 2.9 (1.75-4.9) mIU/mL. Conclusions: In the management of GTD, the use of the free ß-subunit system alone cannot be recommended.

11.
J Obstet Gynaecol Res ; 38(3): 574-7, 2012 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-22353036

RESUMEN

Ritodrine hydrochloride has been widely used for tocolysis, although serious side-effects have been reported. We report two cases of agranulocytosis induced by ritodrine hydrochloride, which probably occurred by different mechanisms. Two patients were hospitalized because of preterm labor and were given intravenous ritodrine hydrochloride. The nadir of neutrocytes was 199/mm(3) and 13/mm(3) in the two cases, respectively. The total dose of ritodrine hydrochloride was calculated to be 7800 mg for 26 days and 2500 mg for 22 days, respectively. The total doses were heavier and administration duration was longer in Case 1, which suggested a toxic mechanism of agranulocytosis, while in Case 2, they were smaller and shorter, suggesting an immunological mechanism. For patients receiving ritodrine hydrochloride, the white blood cell count should be checked frequently regardless of the duration of therapy and a drug lymphocyte stimulation test should be performed.


Asunto(s)
Agranulocitosis/inducido químicamente , Trabajo de Parto Prematuro/tratamiento farmacológico , Ritodrina/efectos adversos , Tocolíticos/efectos adversos , Adulto , Agranulocitosis/diagnóstico , Femenino , Humanos , Embarazo , Ritodrina/uso terapéutico , Tocolíticos/uso terapéutico
12.
J Obstet Gynaecol Res ; 38(3): 597-600, 2012 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-22353374

RESUMEN

In general, primary amenorrhea is caused by gonadal dysgenesis, anomalies of internal or external genitalia with or without chromosomal anomalies, and sometimes by hormonal abnormalities that affect the hypothalamus, pituitary, ovaries, adrenals or thyroid, or by chronic or metabolic diseases. We report a rare case of a juvenile granulosa-cell tumor of the ovary that caused primary amenorrhea in a 16-year-old girl. Her hormonal profiles before the operation were characterized by an extremely low level of follicle-stimulating hormone (FSH), a relatively low level of estradiol and a high level of inhibin B. The patient had menarche after the removal of the tumor. Her elevated serum FSH after the operation was the result of a decreased serum level of inhibin that had been produced by the tumor. The present case highlights that a granulosa-cell tumor, known as an inhibin-secreting tumor, should be considered when treating primary amenorrheic girls.


Asunto(s)
Amenorrea/etiología , Tumor de Células de la Granulosa/diagnóstico , Adolescente , Femenino , Tumor de Células de la Granulosa/complicaciones , Humanos
13.
J Reprod Med ; 57(7-8): 325-8, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22838249

RESUMEN

OBJECTIVE: To examine whether preeclampsia is a predictive factor for fetal prognosis in complete hydatidiform mole coexistent with twin fetus (CHMCF). STUDY DESIGN: We performed a retrospective chart review for 17 cases of definitive CHMCF managed in our hospital between 1991 and 2011. RESULTS: Fifteen patients chose expectant management and the remaining 2 selected termination of the pregnancy. During expectant management 6 patients displayed hypertension with proteinuria, representing preeclampsia, by the 2nd trimester (11-24 weeks) and the other 9 did not (nonpreeclamptic). No babies from preeclamptic mothers survived, with 5 intrauterine fetal deaths at 16-29 weeks and 1 neonatal death at 22 weeks. By contrast, 5 babies from 9 nonpreeclamptic mothers (1 preterm delivery at 29 weeks and 4 term deliveries) survived, while 4 pregnancies were lost by spontaneous abortion at 11-19 weeks. Low-risk gestational trophoblastic neoplasia (GTN) eventually occurred in both preeclamptic (4 of 6) and nonpreeclamptic (4 of 11) cases. Complicating preeclampsia correlated significantly with fetal demise and an increasing trend in serum hCG level but not with postmolar GTN. CONCLUSION: Complicating preeclampsia predicts poor survival of the fetus, but not subsequent GTN, in CHMCF.


Asunto(s)
Muerte Fetal/etiología , Mola Hidatiforme/complicaciones , Preeclampsia/diagnóstico , Embarazo Gemelar , Neoplasias Uterinas/complicaciones , Aborto Espontáneo/etiología , Aborto Terapéutico , Adulto , Gonadotropina Coriónica/sangre , Femenino , Enfermedad Trofoblástica Gestacional/complicaciones , Humanos , Nacimiento Vivo , Embarazo , Estudios Retrospectivos , Adulto Joven
14.
J Reprod Med ; 57(5-6): 243-8, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22696820

RESUMEN

OBJECTIVE: To review current follow-up measures of human chorionic gonadotropin (hCG) in uneventful postmolar patients, and to evaluate criteria for initiating chemotherapy. STUDY DESIGN: Between 1993 and 2011 hCG data from 395 patients with uneventful complete moles (CMs) (195 patients) and partial moles (PMs) (205 patients) were obtained at 4 hospitals in Japan. All patients had been followed regularly at various intervals based on the preceding hCG titers and normal hCG regression curve. RESULTS: All patients achieved hCG normalization spontaneously (range, 3.1-29.7 weeks). Approximately half of the patients with CM and PM had attained an undetectable hCG level at 9.3 and 8.3 weeks after evacuation of mole, respectively. The reconstructed normal hCG regression curve consisted of hCG levels of 1,000 mIU/mL at 5 weeks, 100 mIU/mL at 8 weeks and nondetectable hCG levels at 24 weeks. Plotting preceding hCG titers on this hCG regression curve, the intervals of visits to measure hCG were changing, and the real number of visits was significantly fewer than that of recommended weekly measurement of hCG (p<0.0001). CONCLUSION: The use of the present hCG regression curve after evacuation of a molar pregnancy can aid in estimation of the risk of developing gestational trophoblastic neoplasia, especially in women who have suboptimal compliance and follow-up.


Asunto(s)
Gonadotropina Coriónica/sangre , Mola Hidatiforme/sangre , Neoplasias Uterinas/sangre , Femenino , Humanos , Mola Hidatiforme/cirugía , Japón , Embarazo , Factores de Tiempo , Neoplasias Uterinas/cirugía
15.
J Obstet Gynaecol Res ; 37(12): 1818-23, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21827570

RESUMEN

AIMS: The aim of this study was to examine the factors that influence soluble endothelial selectin (sE-selectin) levels in umbilical cord serum. MATERIALS AND METHODS: sE-selectin levels in umbilical cord serum were measured in 144 patients using enzyme-linked immunosorbent assay. We examined the association of sE-selectin levels with gestational age, pre-eclampsia (PE), histological chorioamnionitis (HCAM), preterm premature rupture of membranes, magnesium sulfate use, birthweight, and placental weight. RESULTS: A significant positive correlation was observed between sE-selectin levels and gestational age in the patients who had neither PE nor HCAM (r = 0.559, P < 0.0001). This statistically positive correlation persisted in patients with PE without HCAM (n = 25, r = 0.644, P < 0.001), but not in patients with HCAM without PE (n = 58, r = 0.102, P = 0.448). In matched gestational age analysis, sE-selectin levels were increased in the presence of HCAM (P = 0.0006), but were not influenced by the presence of PE (P = 0.127), preterm premature rupture of membranes (P = 0.352) or magnesium sulfate use (P = 0.337). CONCLUSION: sE-selectin levels in umbilical cord serum were positively correlated with gestational weeks. sE-selectin levels in umbilical cord serum were higher in mothers with HCAM but not with PE, when compared with gestational-age-matched controls.


Asunto(s)
Corioamnionitis/metabolismo , Selectina E/sangre , Sangre Fetal/metabolismo , Preeclampsia/metabolismo , Adulto , Femenino , Edad Gestacional , Humanos , Recién Nacido , Masculino , Placenta/metabolismo , Embarazo
16.
Gan To Kagaku Ryoho ; 38(13): 2639-41, 2011 Dec.
Artículo en Japonés | MEDLINE | ID: mdl-22189233

RESUMEN

Malignant peritoneal mesothelioma is extremely rare, and its prognosis is poor. The median survival period is said to be approximately one year after diagnosis. We report a case of recurrent malignant peritoneal mesothelioma treated with concurrent chemoradiotherapy (CCRT). The patient has been alive for six years without recurrence. This report seems to be the first that indicates CCRT to be useful for peritoneal mesothelioma. The patient was a 21-year-old woman who underwent emergency surgery of the in acute abdomen at another hospital. The resected tumor was 18 cm in size and pathological examination revealed that it was a malignant mesothelioma of the epithelioid type. CAP therapy (cyclophosphamide+adriamycine+cisplatin)+CPT-11 administration was given only one course, and the patient was then transferred to our hospital. She underwent resection of the residual disease and six courses of TC therapy (paclitaxel+carboplatin) as adjuvant chemotherapy. Twelve months after chemotherapy, pelvic recurrence occurred. We attempted surgery but only biopsy could be performed because of a pelvic wall invasion. The patient underwent CCRT with weekly cisplatin. The tumor was reduced by irradiation of 50. 4 Gy and disappeared after 6 months. No recurrence has been found six years since the last treatment. CCRT might be effective against malignant peritoneal mesothelioma of the epithelioid type.


Asunto(s)
Quimioradioterapia , Mesotelioma/terapia , Neoplasias Peritoneales/terapia , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Femenino , Humanos , Inducción de Remisión , Adulto Joven
17.
Respir Investig ; 59(6): 810-818, 2021 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-34565716

RESUMEN

BACKGROUND: The fourth wave of COVID-19 in Osaka Prefecture, Japan, caused a medical crisis. Here, we aim to identify the risk factors for COVID-19 severity and compare patients between the first-third waves and the fourth wave. METHODS: We performed an observational retrospective study of COVID-19 cases at the National Hospital Organization Kinki-Chuo Chest Medical Center. RESULTS: We identified 404 patients (median age: 71.0 years [interquartile range: 56.0-80.0]), of whom 199 (49.1%) had mild disease, 142 (35.2%) had moderate disease, and 63 (15.6%) had severe disease. The overall mortality rate was 5.4% (22/404). Based on multivariate logistic regression analysis, cardiovascular disease, fever, dyspnea, and several inflammatory biomarkers were independent risk factors for moderate to severe disease. For every 1 mg/dL increase in C-reactive protein, 10 IU/L increase in lactate dehydrogenase, and 100 ng/mL increase in ferritin, the risk for moderate to severe disease increased by 18.3%, 12.9%, and 8.9%, respectively. Overall disease severity in the fourth wave was higher than in the first-third waves. However, there was no significant difference in mortality. Because of a shortage of beds, four of the 28 severe patients (14.3%) in the fourth wave could not be transferred to the advanced hospital. CONCLUSIONS: Cardiovascular disease, fever, dyspnea, and several inflammatory biomarkers were risk factors for moderate to severe COVID-19 in our cohort. During the fourth wave, COVID-19 severity worsened, increasing the number of patients who could not be transferred to beds for severe cases, resulting in a medical crisis in Osaka.


Asunto(s)
COVID-19/epidemiología , Anciano , Anciano de 80 o más Años , Asma/epidemiología , Comorbilidad , Diabetes Mellitus/epidemiología , Humanos , Hipertensión/epidemiología , Control de Infecciones , Japón/epidemiología , Persona de Mediana Edad , Pandemias , Enfermedad Pulmonar Obstructiva Crónica/epidemiología , Estudios Retrospectivos , Factores de Riesgo , SARS-CoV-2 , Índice de Severidad de la Enfermedad
18.
Respir Investig ; 59(2): 218-222, 2021 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-33069662

RESUMEN

BACKGROUND: Hemoptysis is a frequent and sometimes fatal complication of non-tuberculous mycobacterial (NTM) lung disease. The risk factors for hemoptysis are not well understood. In the current study, potential risk factors for hemoptysis were investigated in patients with Mycobacterium avium complex (MAC) lung disease, which is the most common NTM in Japan. METHODS: Medical records from the Kinki-Chuo Chest Medical Center were reviewed. Consecutive patients with MAC lung disease diagnosed in 2014 and followed up for more than 1 year in the hospital were included in the study. Hemoptysis was confirmed between 2014 and 2016. The characteristics of patients with hemoptysis and non-hemoptysis at the time of the initial diagnosis of MAC lung disease were obtained from the medical records, and the two groups were compared. The radiological findings assessed included nodules, infiltration shadows, cavities, and bronchiectasis. Each was classified and scored individually in six lung fields, and these data were used to generate radiological scores. RESULTS: The study included 82 patients with MAC lung disease, 18 with hemoptysis and 64 without. Higher total radiological severity score at the time of the initial diagnosis of MAC was associated with an increased risk of hemoptysis. Among the radiological scores, infiltration and cavities were marginally associated with the risk of hemoptysis. CONCLUSIONS: The radiological severity score at the time of initial diagnosis of MAC lung disease was associated with hemoptysis.


Asunto(s)
Hemoptisis/etiología , Complejo Mycobacterium avium , Infección por Mycobacterium avium-intracellulare , Neumonía Bacteriana/complicaciones , Neumonía Bacteriana/microbiología , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Neumonía Bacteriana/diagnóstico por imagen , Radiografía Torácica , Factores de Riesgo , Índice de Severidad de la Enfermedad
19.
Langenbecks Arch Surg ; 395(3): 211-6, 2010 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19898861

RESUMEN

PURPOSE: Previous studies have reported that extranodal spread is a prognostic factor in patients with several solid cancers. However, the definition of extranodal spread varies with the reporting investigator and has not been standardized yet. Therefore, we selected several widely used definitions from previous reports and comparatively assessed the clinicopathologic significance of these definitions. METHODS: Extranodal spread in the 103 node-positive patients who had received curative resections for gastric cancer was classified into two groups, viz., (a) capsule rupture, where cancer cells infiltrated into the perinodal fatty tissue beyond the capsule of the involved lymph node, and (b) no capsule rupture, where nests of cancer cells were detected demonstrable in adjacent tissues around the metastatic lymph node without rupture of the capsule. RESULTS: Sixty-five (63.1%) of the 103 patients showed extranodal spread. Of the 65 patients, 50 patients showed the capsule rupture type and 15 showed the no capsule rupture type of extranodal spread. The 5-year survival rate was significantly poorer in the capsule rupture group as compared with that in the no capsule rupture group and extranodal spread-negative group (P < 0.05 and P < 0.01, respectively). In regard to the mode of recurrence, the rate of peritoneal recurrence was significantly higher in the capsule rupture group (P < 0.01). CONCLUSIONS: In the assessment of patients with extranodal spread, it is considered important to classify the patients based on the status of extranodal spread into the capsule rupture group and no capsule rupture group.


Asunto(s)
Ganglios Linfáticos/patología , Neoplasias Gástricas/patología , Femenino , Gastrectomía , Humanos , Escisión del Ganglio Linfático , Metástasis Linfática , Masculino , Persona de Mediana Edad , Estadificación de Neoplasias , Pronóstico , Neoplasias Gástricas/mortalidad , Neoplasias Gástricas/cirugía , Análisis de Supervivencia , Resultado del Tratamiento
20.
Surg Today ; 40(1): 72-5, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20037845

RESUMEN

A 67-year-old man underwent an investigation of epigastric pain and weight loss. Preoperative imaging findings suggested the presence of a tumor, which developed as an epidermoid cyst and originated from an intrapancreatic accessory spleen; however, the possibility of malignancy could not be ruled out. We therefore performed a laparoscopic-assisted distal pancreatectomy with a splenectomy for both diagnostic and treatment purposes. Five laparoscopic ports were created. After the spleen and pancreatic tail were dissected from the retroperitoneum laparoscopically, they were pulled out through a 7-cm left subcostal incision and resected with an endoscopic linear stapler. The operative time was 227 min and the blood loss was 400 ml. The postoperative course was uneventful. The final pathological diagnosis was in agreement with the preoperative diagnosis. This case demonstrates that the minimally invasive approach of laparoscopic surgery can be used safely and successfully for difficult-to-diagnose pancreatic tumors. This is the first report describing a laparoscopic resection of an epidermoid cyst originating from an intrapancreatic accessory spleen.


Asunto(s)
Coristoma/cirugía , Quiste Epidérmico/cirugía , Laparoscopía , Enfermedades Pancreáticas/complicaciones , Bazo , Enfermedades del Bazo/cirugía , Anciano , Coristoma/complicaciones , Quiste Epidérmico/diagnóstico por imagen , Quiste Epidérmico/etiología , Humanos , Masculino , Pancreatectomía/métodos , Enfermedades Pancreáticas/cirugía , Esplenectomía/métodos , Enfermedades del Bazo/diagnóstico por imagen , Enfermedades del Bazo/etiología , Ultrasonografía , Pérdida de Peso
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA